The Effects of Filgrastim on Prognosis of Patients with acute Ischemic Stroke

Phase 2

Recruiting

• Conditions: acute Ischemic Stroke.; Cerebral infarction, unspecified

• Registration Number: IRCT20141209020258N63
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 84

Inclusion Criteria

18 years and more
Patients with acute ischemic stroke

Exclusion Criteria

Drinking alcohol and addict
Incidence of side effects or the sensitivity of the drug
History of blood pressure, diabetes, embolism and DVT
Death of the patient 72 hours after entering the emergency room

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hemoglobin. Timepoint: Before and during treatment and 4 weeks after treatment. Method of measurement: blood test.;Power of the paraplegic organ. Timepoint: Before and during treatment and 4 weeks after treatment. Method of measurement: Physical examination.;Awareness status. Timepoint: Before and during treatment and 4 weeks after treatment. Method of measurement: Glasgow Coma Scale.;Motion status. Timepoint: Before and during treatment and 4 weeks after treatment. Method of measurement: Physical examination.;Hematocrit. Timepoint: Before and during treatment and 4 weeks after treatment. Method of measurement: blood test.